Stocktoria

MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-11-20
Chart by TradingView
1/9
Piotroski F — financial health
1.29
Altman Z″ — distress risk · grey
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$185.7M$259.2M$288.9M$883.0M$799.2M
Gross profit$34.0M$108.3M$140.2M
Operating income-$215.3M-$235.6M-$31.6M$574.2M$554.6M
Net income-$130.8M-$144.8M-$119.0M$220.2M$182.0M
Operating cash flow-$57.6M$7.5M$126.2M$536.0M$368.6M
Free cash flow-$70.7M-$22.2M$60.7M$518.9M$353.7M
Total assets$770.6M$1.0B$1.5B$2.3B$1.9B
Total liabilities$397.9M$431.0M$697.6M$1.4B$1.4B
Shareholders' equity$372.7M$577.2M$789.9M$905.2M$545.4M
Ratios
Gross margin18.3%41.8%48.5%
Operating margin-115.9%-90.9%-11.0%65.0%69.4%
Net margin-70.4%-55.9%-41.2%24.9%22.8%
FCF margin-38.1%-8.6%21.0%58.8%44.3%
Return on assets-17.0%-14.4%-8.0%9.6%9.5%
Return on equity-35.1%-25.1%-15.1%24.3%33.4%
Debt / equity0.78×0.51×0.66×0.58×0.96×
Current ratio6.607.538.007.707.89
Revenue growth-28.3%-10.3%-67.3%10.5%181.3%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC4,264,689$12.1M
Point72 Asset Management, L.P.3,205,496$9.1M

Why these scores methodology →

Piotroski F-score: 1/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 1.29 (grey)

  • Working capital / assets 0.326
  • Retained earnings / assets 0.013
  • EBIT / assets -0.279
  • Equity / liabilities 0.937

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001823239 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.